Should We Include Connection Domain Mutations of HIV-1 Reverse Transcriptase in HIV Resistance Testing?

The author discusses a new study that found a common mutation in the connection domain of reverse transcriptase, a mutation that confers resistance to two antiretroviral drug classes.

Detalles Bibliográficos
Autor principal: Götte, Matthias
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100139/
https://www.ncbi.nlm.nih.gov/pubmed/18052605
http://dx.doi.org/10.1371/journal.pmed.0040346
_version_ 1782138332129525760
author Götte, Matthias
author_facet Götte, Matthias
author_sort Götte, Matthias
collection PubMed
description The author discusses a new study that found a common mutation in the connection domain of reverse transcriptase, a mutation that confers resistance to two antiretroviral drug classes.
format Text
id pubmed-2100139
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-21001392007-12-01 Should We Include Connection Domain Mutations of HIV-1 Reverse Transcriptase in HIV Resistance Testing? Götte, Matthias PLoS Med Perspectives The author discusses a new study that found a common mutation in the connection domain of reverse transcriptase, a mutation that confers resistance to two antiretroviral drug classes. Public Library of Science 2007-12 2007-12-01 /pmc/articles/PMC2100139/ /pubmed/18052605 http://dx.doi.org/10.1371/journal.pmed.0040346 Text en © 2007 Matthias Götte. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Perspectives
Götte, Matthias
Should We Include Connection Domain Mutations of HIV-1 Reverse Transcriptase in HIV Resistance Testing?
title Should We Include Connection Domain Mutations of HIV-1 Reverse Transcriptase in HIV Resistance Testing?
title_full Should We Include Connection Domain Mutations of HIV-1 Reverse Transcriptase in HIV Resistance Testing?
title_fullStr Should We Include Connection Domain Mutations of HIV-1 Reverse Transcriptase in HIV Resistance Testing?
title_full_unstemmed Should We Include Connection Domain Mutations of HIV-1 Reverse Transcriptase in HIV Resistance Testing?
title_short Should We Include Connection Domain Mutations of HIV-1 Reverse Transcriptase in HIV Resistance Testing?
title_sort should we include connection domain mutations of hiv-1 reverse transcriptase in hiv resistance testing?
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100139/
https://www.ncbi.nlm.nih.gov/pubmed/18052605
http://dx.doi.org/10.1371/journal.pmed.0040346
work_keys_str_mv AT gottematthias shouldweincludeconnectiondomainmutationsofhiv1reversetranscriptaseinhivresistancetesting

Ejemplares similares